Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $240.4 million.

  • Cellebrite DI's Shares Outstanding (Weighted Average) rose 20.81% to $240.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.4 million, marking a year-over-year increase of 20.81%. This contributed to the annual value of $208.7 million for FY2024, which is 8.95% up from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Shares Outstanding (Weighted Average) is $240.4 million, which was up 1.31% from $237.2 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Shares Outstanding (Weighted Average) registered a high of $240.4 million during Q3 2025, and its lowest value of $75.0 million during Q1 2021.
  • For the 3-year period, Cellebrite DI's Shares Outstanding (Weighted Average) averaged around $207.1 million, with its median value being $198.9 million (2024).
  • Per our database at Business Quant, Cellebrite DI's Shares Outstanding (Weighted Average) soared by 174.55% in 2021 and then declined by 1.90% in 2023.
  • Quarterly analysis of 5 years shows Cellebrite DI's Shares Outstanding (Weighted Average) stood at $180.2 million in 2021, then grew by 1.72% to $183.3 million in 2022, then grew by 4.52% to $191.6 million in 2023, then rose by 8.95% to $208.7 million in 2024, then climbed by 20.81% to $240.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $240.4 million in Q3 2025, compared to $237.2 million in Q2 2025 and $239.5 million in Q1 2025.